These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20566489)

  • 1. Out of the frying-pan into the fire: a supraventricular tachycardia triggering a ventricular tachycardia in a patient with ischaemic cardiomyopathy and an implantable-cardioverter defibrillator.
    Sorgente A; de Asmundis C; Chierchia GB; Brugada P
    Eur Heart J; 2010 Oct; 31(19):2368. PubMed ID: 20566489
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade.
    Kantharia BK; Patel JA; Nagra BS; Ledley GS
    Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do traditional VT zones improve outcome in primary prevention ICD patients?
    Duncan E; Thomas G; Johns N; Pfeffer C; Appanna G; Shah N; Hunter R; Finlay M; Schilling RJ; Sporton S
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1353-8. PubMed ID: 20727095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.
    Borleffs CJ; van Welsenes GH; van Bommel RJ; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Rosendaal FR; Schalij MJ
    Eur Heart J; 2010 Mar; 31(6):712-8. PubMed ID: 19933693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing.
    Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial diagnostics in a tiered therapy implantable defibrillator.
    Tang C; Schwartz M; Yeung-Lai-Wah JA
    Can J Cardiol; 1997 May; 13(5):446-8. PubMed ID: 9179082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator oversensing: what is the mechanism?
    Vijayaraman P; Ferrell MS; Rhee B; Elam G; Kok LC
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):723-4. PubMed ID: 15175071
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
    Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of ventricular tachycardia by far-field stimulation in humans: a feasibility study.
    Lawo T; Schrader J; Buddensiek M; Schweika O; Mügge A; Bösche LI
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1540-7. PubMed ID: 21039638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging.
    Bernier M; Essebag V
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e81-3. PubMed ID: 20230474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine ceases electrical storm in an ablated patient with an implantable cardioverter-defibrillator: an old lady in the modern era.
    Georgiadou P; Iliodromitis EK; Theodorakis GN; Kremastinos DT
    Int J Cardiol; 2006 Oct; 113(1):129-31. PubMed ID: 16318889
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy.
    Dilaveris P; Pietri P; Tsiachris D; Gatzoulis K; Stefanadis C
    Circulation; 2012 Feb; 125(7):967-9. PubMed ID: 22354978
    [No Abstract]   [Full Text] [Related]  

  • 18. Supraventricular arrhythmia induction by an implantable cardioverter defibrillator in a patient with hypertrophic cardiomyopathy.
    Akbarzadeh F; Kazemi B; Pourafkari L
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):372-6. PubMed ID: 19744274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary bypass surgery and cardioverter-defibrillator implanted in patients with malignant ventricular arrhythmia and ischemic cardiopathy].
    Primo J; Geelen P; Lorga Filho A; Wellens F; Brugada P
    Rev Port Cardiol; 1998 Feb; 17(2):163-7. PubMed ID: 9587212
    [No Abstract]   [Full Text] [Related]  

  • 20. Death due to an implantable cardioverter defibrillator.
    Messali A; Thomas O; Chauvin M; Coumel P; Leenhardt A
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):953-6. PubMed ID: 15333095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.